IPW
IDXX icon

Invictus Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Invictus Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Sell
700
-100
-13% -$56.1K 0.02% 70
2026
Q1 		$450K Buy
+800
New +$513K 0.03% 60

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Invictus Private Wealth's IDXX Position: Q2 2026 in Review

Invictus Private Wealth reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $56.1K and leaving 700 shares worth $369K. The position accounts for 0.02% of the portfolio, ranked #70.

Invictus Private Wealth first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $450K in Q1 2026. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Invictus Private Wealth held 700 shares of Idexx Laboratories worth $369K as of Q2 2026.
  • Invictus Private Wealth sold 100 Idexx Laboratories shares in Q2 2026, an estimated $56.1K.
  • Idexx Laboratories made up 0.02% of Invictus Private Wealth's portfolio in Q2 2026, its #70 holding.
  • Invictus Private Wealth first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Invictus Private Wealth's Idexx Laboratories position peaked at $450K in Q1 2026.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Invictus Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.